Ethical Naturals' AlphaWave L-Theanine earns TGA approval for sale in Australian market
According to Ethical Naturals, the approval was the result of 18 months of work by the company and Transchem, its Australian partner and exclusive distributor of AlphaWave in the country.
Photo © AdobeStock.com/Thomas Pajot
Ethical Naturals Inc. (ENI; Novato, CA) has announced that its Alpha Wave L-Theanine has been approved by the Australian Therapeutic Goods Administration (TGA) for sale in the country. According to Ethical Naturals, the approval was the result of 18 months of work by the company and Transchem, its Australian partner and exclusive distributor of AlphaWave in the country.
“The application process through TGA is extremely vigorous in respect to both safety and efficacy,” said Cal Bewicke, CEO of ENI, in a press release. “It examines in-depth the manufacturing system, the analytical methods used and clinical data. When it comes down to it, though it took us a year and a half, we consider it a privilege to have our product put under a detailed microscope by an organization so informed as TGA.”
ENI’s AlphaWave L-Theanine has been available in the U.S.for over ten years, and is GRAS (generally recognized as safe) for use in food and beverage products. ENI states in a press release that the product’s stress-support and cognitive health benefits have been supported by two clinical studies, with a third nearing completion. The most recent study found that a 200 mg dose of the product significantly increased frontal region alpha power and reduced the salivary cortisol.1
Reference
- Evans, M.; McDonald, A.C.; Xiong, L.; Crowley, D.C.; Guthrie, N. A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® L-Theanine on Stress in a Healthy Adult Population. Neurology and Therapy, 2021, 10: 1061-1078. DOI: 10.1007%2Fs40120-021-00284-x
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
